A carregar...
Sorafenib induced acral pigmentation: A new entity
Sorafenib is a multikinase inhibitor commonly used for the treatment of advanced renal cell and hepatocellular carcinoma. The commonly reported dermatological adverse effects of Sorafenib include hand-foot syndrome (HFS), alopecia, pruritus, facial and scalp erythema, splinter hemorrhages, keratoaca...
Na minha lista:
| Publicado no: | Avicenna J Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394572/ https://ncbi.nlm.nih.gov/pubmed/25878967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-0770.154199 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|